Marion Cardizem SR
Executive Summary
Generates $19 mil. sales in first quarter FY 1990 sales. First quarter sales of Marion's immediate-release Cardizem totaled $162 mil., bringing combined Cardizem line sales to $181 mil., up 39% over the same period in FY 1989. Carafate sales in the quarter were down 23% to $30 mil. Overall, Marion sales grew 15% to $237 mil.; earnings were up 29% before taking into account special charges associated with the merger with Merrell Dow.